Skip to main content
Top
Published in: Diabetologia 1/2014

01-01-2014 | Meta-analysis

HbA1c, fasting and 2 h plasma glucose in current, ex- and never-smokers: a meta-analysis

Authors: Soraya Soulimane, Dominique Simon, William H. Herman, Celine Lange, Crystal M. Y. Lee, Stephen Colagiuri, Jonathan E. Shaw, Paul Z. Zimmet, Dianna Magliano, Sandra R. G. Ferreira, Yanghu Dong, Lei Zhang, Torben Jorgensen, Jaakko Tuomilehto, Viswanathan Mohan, Dirk L. Christensen, Lydia Kaduka, Jacqueline M. Dekker, Giel Nijpels, Coen D. A. Stehouwer, Olivier Lantieri, Wilfred Y. Fujimoto, Donna L. Leonetti, Marguerite J. McNeely, Knut Borch-Johnsen, Edward J. Boyko, Dorte Vistisen, Beverley Balkau, on behalf of the DETECT-2 Study Group, DESIR Study Group

Published in: Diabetologia | Issue 1/2014

Login to get access

Abstract

Aims/Hypothesis

The relationships between smoking and glycaemic variables have not been well explored. We compared HbA1c, fasting plasma glucose (FPG) and 2 h plasma glucose (2H-PG) in current, ex- and never-smokers.

Methods

This meta-analysis used individual data from 16,886 men and 18,539 women without known diabetes in 12 DETECT-2 consortium studies and in the French Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) and Telecom studies. Means of three glycaemic variables in current, ex- and never-smokers were modelled by linear regression, with study as a random factor. The I 2 statistic was used to evaluate heterogeneity among studies.

Results

HbA1c was 0.10% (95% CI 0.08, 0.12) (1.1 mmol/mol [0.9, 1.3]) higher in current smokers and 0.03% (0.01, 0.05) (0.3 mmol/mol [0.1, 0.5]) higher in ex-smokers, compared with never-smokers. For FPG, there was no significant difference between current and never-smokers (−0.004 mmol/l [−0.03, 0.02]) but FPG was higher in ex-smokers (0.12 mmol/l [0.09, 0.14]). In comparison with never-smokers, 2H-PG was lower (−0.44 mmol/l [−0.52, −0.37]) in current smokers, with no difference for ex-smokers (0.02 mmol/l [−0.06, 0.09]). There was a large and unexplained heterogeneity among studies, with I 2 always above 50%; I 2 was little changed after stratification by sex and adjustment for age and BMI. In this study population, current smokers had a prevalence of diabetes that was 1.30% higher as screened by HbA1c and 0.52% lower as screened by 2H-PG, in comparison with never-smokers.

Conclusion/interpretation

Across this heterogeneous group of studies, current smokers had a higher HbA1c and lower 2H-PG than never-smokers. This will affect the chances of smokers being diagnosed with diabetes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J (2007) Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 298:2654–2664PubMedCrossRef Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J (2007) Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 298:2654–2664PubMedCrossRef
2.
go back to reference Sicree RA, Zimmet PZ, Dunstan DW, Cameron AJ, Welborn TA, Shaw JE (1988) Differences in height explain gender differences in the response to the oral glucose tolerance test—the AusDiab study. Diabet Med 25:296–302CrossRef Sicree RA, Zimmet PZ, Dunstan DW, Cameron AJ, Welborn TA, Shaw JE (1988) Differences in height explain gender differences in the response to the oral glucose tolerance test—the AusDiab study. Diabet Med 25:296–302CrossRef
3.
go back to reference DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group (1998) Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. BMJ 317:371–375CrossRef DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group (1998) Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. BMJ 317:371–375CrossRef
4.
go back to reference Borg R, Vistisen D, Witte DR, Borch-Johnsen K (2010) Comparing risk profiles of individuals diagnosed with diabetes by OGTT and HbA1c. The Danish Inter99 study. Diabet Med 27:906–910PubMedCrossRef Borg R, Vistisen D, Witte DR, Borch-Johnsen K (2010) Comparing risk profiles of individuals diagnosed with diabetes by OGTT and HbA1c. The Danish Inter99 study. Diabet Med 27:906–910PubMedCrossRef
5.
go back to reference Simon D, Senan C, Garnier P, Saint-Paul M, Papoz L (1989) Epidemiological features of glycated haemoglobin A1c-distribution in a healthy population. The Telecom Study. Diabetologia 32:864–869PubMedCrossRef Simon D, Senan C, Garnier P, Saint-Paul M, Papoz L (1989) Epidemiological features of glycated haemoglobin A1c-distribution in a healthy population. The Telecom Study. Diabetologia 32:864–869PubMedCrossRef
6.
go back to reference Yudkin JS, Forrest RD, Jackson CA, Ryle AJ, Davie S, Gould BJ (1990) Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Diabetologia 33:208–215PubMedCrossRef Yudkin JS, Forrest RD, Jackson CA, Ryle AJ, Davie S, Gould BJ (1990) Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Diabetologia 33:208–215PubMedCrossRef
7.
go back to reference Nilsson PM, Lind L, Pollare T, Berne C, Lithell HO (1995) Increased level of hemoglobin A1C but not impaired insulin sensitivity, found in hypertensive and normotensive smokers. Metabolism 44:557–561PubMedCrossRef Nilsson PM, Lind L, Pollare T, Berne C, Lithell HO (1995) Increased level of hemoglobin A1C but not impaired insulin sensitivity, found in hypertensive and normotensive smokers. Metabolism 44:557–561PubMedCrossRef
8.
go back to reference Sargeant LA, Khaw KT, Bingham S et al (2001) Cigarette smoking and glycaemia: the EPIC-Norfolk Study. European Prospective Investigation into Cancer. Int J Epidemiol 30:547–554PubMedCrossRef Sargeant LA, Khaw KT, Bingham S et al (2001) Cigarette smoking and glycaemia: the EPIC-Norfolk Study. European Prospective Investigation into Cancer. Int J Epidemiol 30:547–554PubMedCrossRef
9.
go back to reference Cho NH, Chan JC, Jang HC, Lim S, Kim HL, Choi SH (2009) Cigarette smoking is an independent risk factor for type 2 diabetes: a four-year community-based prospective study. Clin Endocrinol (Oxf) 71:679–685CrossRef Cho NH, Chan JC, Jang HC, Lim S, Kim HL, Choi SH (2009) Cigarette smoking is an independent risk factor for type 2 diabetes: a four-year community-based prospective study. Clin Endocrinol (Oxf) 71:679–685CrossRef
10.
go back to reference Clair C, Bitton A, Meigs JB, Rigotti NA (2011) Relationships of cotinine and self-reported cigarette smoking with hemoglobin A1c in the U.S.: results from the National Health and Nutrition Examination Survey, 1999-2008. Diabetes Care 34:2250–2255PubMedCrossRef Clair C, Bitton A, Meigs JB, Rigotti NA (2011) Relationships of cotinine and self-reported cigarette smoking with hemoglobin A1c in the U.S.: results from the National Health and Nutrition Examination Survey, 1999-2008. Diabetes Care 34:2250–2255PubMedCrossRef
11.
go back to reference Wareham NJ, Ness EM, Byrne CD, Cox BD, Day NE, Hales CN (1996) Cigarette smoking is not associated with hyperinsulinemia: evidence against a causal relationship between smoking and insulin resistance. Metabolism 45:1551–1556PubMedCrossRef Wareham NJ, Ness EM, Byrne CD, Cox BD, Day NE, Hales CN (1996) Cigarette smoking is not associated with hyperinsulinemia: evidence against a causal relationship between smoking and insulin resistance. Metabolism 45:1551–1556PubMedCrossRef
12.
go back to reference Frati AC, Iniestra F, Ariza CR (1996) Acute effect of cigarette smoking on glucose tolerance and other cardiovascular risk factors. Diabetes Care 19:112–118PubMedCrossRef Frati AC, Iniestra F, Ariza CR (1996) Acute effect of cigarette smoking on glucose tolerance and other cardiovascular risk factors. Diabetes Care 19:112–118PubMedCrossRef
13.
go back to reference Masulli M, Riccardi G, Galasso R, Vaccaro O (2006) Relationship between smoking habits and the features of the metabolic syndrome in a non-diabetic population. Nutr Metab Cardiovasc Dis 16:364–370PubMedCrossRef Masulli M, Riccardi G, Galasso R, Vaccaro O (2006) Relationship between smoking habits and the features of the metabolic syndrome in a non-diabetic population. Nutr Metab Cardiovasc Dis 16:364–370PubMedCrossRef
14.
go back to reference Dunstan DW, Zimmet PZ, Welborn TA et al (2002) The Australian Diabetes, Obesity and Lifestyle Study (AusDiab)—methods and response rates. Diabetes Res Clin Pract 57:119–129PubMedCrossRef Dunstan DW, Zimmet PZ, Welborn TA et al (2002) The Australian Diabetes, Obesity and Lifestyle Study (AusDiab)—methods and response rates. Diabetes Res Clin Pract 57:119–129PubMedCrossRef
15.
go back to reference Gimeno SG, Ferreira SR, Franco LJ, Hirai AT, Matsumura L, Moises RS (2002) Prevalence and 7-year incidence of type II diabetes mellitus in a Japanese-Brazilian population: an alarming public health problem. Diabetologia 45:1635–1638PubMedCrossRef Gimeno SG, Ferreira SR, Franco LJ, Hirai AT, Matsumura L, Moises RS (2002) Prevalence and 7-year incidence of type II diabetes mellitus in a Japanese-Brazilian population: an alarming public health problem. Diabetologia 45:1635–1638PubMedCrossRef
16.
go back to reference Zhou X, Pang Z, Gao W et al (2011) Fresh vegetable intake and prevalence of diabetes in a Chinese population in Qingdao. Diabetes Res Clin Pract 92:137–142PubMedCrossRef Zhou X, Pang Z, Gao W et al (2011) Fresh vegetable intake and prevalence of diabetes in a Chinese population in Qingdao. Diabetes Res Clin Pract 92:137–142PubMedCrossRef
17.
go back to reference Glumer C, Jorgensen T, Borch-Johnsen K (2003) Prevalences of diabetes and impaired glucose regulation in a Danish population: the Inter99 study. Diabetes Care 26:2335–2340PubMedCrossRef Glumer C, Jorgensen T, Borch-Johnsen K (2003) Prevalences of diabetes and impaired glucose regulation in a Danish population: the Inter99 study. Diabetes Care 26:2335–2340PubMedCrossRef
18.
go back to reference Herman WH, Ali MA, Aubert RE et al (1995) Diabetes mellitus in Egypt: risk factors and prevalence. Diabet Med 12:1126–1131PubMedCrossRef Herman WH, Ali MA, Aubert RE et al (1995) Diabetes mellitus in Egypt: risk factors and prevalence. Diabet Med 12:1126–1131PubMedCrossRef
19.
go back to reference Stengard JH, Tuomilehto J, Pekkanen J et al (1992) Diabetes mellitus, impaired glucose tolerance and mortality among elderly men: the Finnish cohorts of the Seven Countries Study. Diabetologia 35:760–765PubMed Stengard JH, Tuomilehto J, Pekkanen J et al (1992) Diabetes mellitus, impaired glucose tolerance and mortality among elderly men: the Finnish cohorts of the Seven Countries Study. Diabetologia 35:760–765PubMed
20.
go back to reference Deepa M, Pradeepa R, Rema M et al (2003) The Chennai Urban Rural Epidemiology Study (CURES)—study design and methodology (urban component) (CURES-I). J Assoc Physicians India 51:863–870PubMed Deepa M, Pradeepa R, Rema M et al (2003) The Chennai Urban Rural Epidemiology Study (CURES)—study design and methodology (urban component) (CURES-I). J Assoc Physicians India 51:863–870PubMed
21.
go back to reference Christensen DL, Friis H, Mwaniki DL et al (2009) Prevalence of glucose intolerance and associated risk factors in rural and urban populations of different ethnic groups in Kenya. Diabetes Res Clin Pract 84:303–310PubMedCrossRef Christensen DL, Friis H, Mwaniki DL et al (2009) Prevalence of glucose intolerance and associated risk factors in rural and urban populations of different ethnic groups in Kenya. Diabetes Res Clin Pract 84:303–310PubMedCrossRef
22.
go back to reference de Vegt F, Dekker JM, Ruhe HG et al (1999) Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia 42:926–931PubMedCrossRef de Vegt F, Dekker JM, Ruhe HG et al (1999) Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia 42:926–931PubMedCrossRef
23.
go back to reference Colagiuri S, Colagiuri R, Na’ati S, Muimuiheata S, Hussain Z, Palu T (2002) The prevalence of diabetes in the Kingdom of Tonga. Diabetes Care 25:1378–1383PubMedCrossRef Colagiuri S, Colagiuri R, Na’ati S, Muimuiheata S, Hussain Z, Palu T (2002) The prevalence of diabetes in the Kingdom of Tonga. Diabetes Care 25:1378–1383PubMedCrossRef
24.
go back to reference Fugimoto W, Boyko EJ, Leonetti DL, Bergstrom R, Newell-Morris L, Wahl PW (1996) Hypertension in Japanese Americans: the Seattle Japanese-American Community Study. Public Health Rep III (Suppl 2):S56–S58 Fugimoto W, Boyko EJ, Leonetti DL, Bergstrom R, Newell-Morris L, Wahl PW (1996) Hypertension in Japanese Americans: the Seattle Japanese-American Community Study. Public Health Rep III (Suppl 2):S56–S58
25.
go back to reference Alexander CM, Landsman PB, Teutsch SM, Haffner SM (2003) NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52:1210–1214PubMedCrossRef Alexander CM, Landsman PB, Teutsch SM, Haffner SM (2003) NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52:1210–1214PubMedCrossRef
26.
go back to reference Balkau B, Lange C, Fezeu L et al (2008) Predicting diabetes: clinical, biological, and genetic approaches: data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 31:2056–2061PubMedCrossRef Balkau B, Lange C, Fezeu L et al (2008) Predicting diabetes: clinical, biological, and genetic approaches: data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 31:2056–2061PubMedCrossRef
27.
go back to reference Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analysis. BMJ 327:557–560PubMedCrossRef Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analysis. BMJ 327:557–560PubMedCrossRef
28.
go back to reference Soulimane S, Simon D, Shaw JE et al (2011) Comparing incident diabetes as defined by fasting plasma glucose or by HbA(1c). The AusDiab, Inter99 and DESIR studies. Diabet Med 28:1311–1318PubMedCrossRef Soulimane S, Simon D, Shaw JE et al (2011) Comparing incident diabetes as defined by fasting plasma glucose or by HbA(1c). The AusDiab, Inter99 and DESIR studies. Diabet Med 28:1311–1318PubMedCrossRef
29.
go back to reference Soulimane S, Simon D, Shaw J et al (2012) HbA1c, fasting plasma glucose and the prediction of diabetes: Inter99, AusDiab and D.E.S.I.R. Diabetes Res Clin Pract 96:392–399PubMedCrossRef Soulimane S, Simon D, Shaw J et al (2012) HbA1c, fasting plasma glucose and the prediction of diabetes: Inter99, AusDiab and D.E.S.I.R. Diabetes Res Clin Pract 96:392–399PubMedCrossRef
30.
go back to reference Consensus Committee (2007) Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation. Diabetes Care 30:2399–2400CrossRef Consensus Committee (2007) Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation. Diabetes Care 30:2399–2400CrossRef
31.
go back to reference The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986CrossRef The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986CrossRef
32.
go back to reference Manley S (2003) Haemoglobin A1c—a marker for complications of type 2 diabetes: the experience from the UK Prospective Diabetes Study (UKPDS). Clin Chem Lab Med 41:1182–1190PubMed Manley S (2003) Haemoglobin A1c—a marker for complications of type 2 diabetes: the experience from the UK Prospective Diabetes Study (UKPDS). Clin Chem Lab Med 41:1182–1190PubMed
33.
go back to reference Eliasson B (2003) Cigarette smoking and diabetes. Prog Cardiovasc Dis 45:405–413PubMed Eliasson B (2003) Cigarette smoking and diabetes. Prog Cardiovasc Dis 45:405–413PubMed
34.
go back to reference Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM (1992) Insulin resistance and cigarette smoking. Lancet 339:1128–1130PubMedCrossRef Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM (1992) Insulin resistance and cigarette smoking. Lancet 339:1128–1130PubMedCrossRef
35.
go back to reference Higgins T, Cembrowski G, Tran D, Lim E, Chan J (2009) Influence of variables on hemoglobin A1c values and nonheterogeneity of hemoglobin A1c reference ranges. J Diabetes Sci Technol 3:644–648PubMed Higgins T, Cembrowski G, Tran D, Lim E, Chan J (2009) Influence of variables on hemoglobin A1c values and nonheterogeneity of hemoglobin A1c reference ranges. J Diabetes Sci Technol 3:644–648PubMed
36.
go back to reference Smith RJ, Koenig RJ, Binnerts A, Soeldner JS, Aoki TT (1982) Regulation of hemoglobin AIc formation in human erythrocytes in vitro. Effects of physiologic factors other than glucose. J Clin Invest 69:1164–1168PubMedCrossRef Smith RJ, Koenig RJ, Binnerts A, Soeldner JS, Aoki TT (1982) Regulation of hemoglobin AIc formation in human erythrocytes in vitro. Effects of physiologic factors other than glucose. J Clin Invest 69:1164–1168PubMedCrossRef
37.
go back to reference Beutler E (1975) The effect of carbon monoxide on red cell life span in sickle cell disease. Blood 46:253–259PubMed Beutler E (1975) The effect of carbon monoxide on red cell life span in sickle cell disease. Blood 46:253–259PubMed
38.
go back to reference Kohagen KR, Kim MS, McDonnell WM, Chey WD, Owyang C, Hasler WL (1996) Nicotine effects on prostaglandin-dependent gastric slow wave rhythmicity and antral motility in nonsmokers and smokers. Gastroenterology 110:3–11PubMedCrossRef Kohagen KR, Kim MS, McDonnell WM, Chey WD, Owyang C, Hasler WL (1996) Nicotine effects on prostaglandin-dependent gastric slow wave rhythmicity and antral motility in nonsmokers and smokers. Gastroenterology 110:3–11PubMedCrossRef
39.
go back to reference Johnson RD, Horowitz M, Maddox AF, Wishart JM, Shearman DJ (1991) Cigarette smoking and rate of gastric emptying: effect on alcohol absorption. BMJ 302:20–23PubMedCrossRef Johnson RD, Horowitz M, Maddox AF, Wishart JM, Shearman DJ (1991) Cigarette smoking and rate of gastric emptying: effect on alcohol absorption. BMJ 302:20–23PubMedCrossRef
40.
41.
go back to reference Janzon L, Berntorp K, Hanson M, Lindell SE, Trell E (1983) Glucose tolerance and smoking: a population study of oral and intravenous glucose tolerance tests in middle-aged men. Diabetologia 25:86–88PubMedCrossRef Janzon L, Berntorp K, Hanson M, Lindell SE, Trell E (1983) Glucose tolerance and smoking: a population study of oral and intravenous glucose tolerance tests in middle-aged men. Diabetologia 25:86–88PubMedCrossRef
42.
go back to reference Hills SA, Balkau B, Coppack SW et al (2004) The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives. Diabetologia 47:566–570PubMedCrossRef Hills SA, Balkau B, Coppack SW et al (2004) The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives. Diabetologia 47:566–570PubMedCrossRef
Metadata
Title
HbA1c, fasting and 2 h plasma glucose in current, ex- and never-smokers: a meta-analysis
Authors
Soraya Soulimane
Dominique Simon
William H. Herman
Celine Lange
Crystal M. Y. Lee
Stephen Colagiuri
Jonathan E. Shaw
Paul Z. Zimmet
Dianna Magliano
Sandra R. G. Ferreira
Yanghu Dong
Lei Zhang
Torben Jorgensen
Jaakko Tuomilehto
Viswanathan Mohan
Dirk L. Christensen
Lydia Kaduka
Jacqueline M. Dekker
Giel Nijpels
Coen D. A. Stehouwer
Olivier Lantieri
Wilfred Y. Fujimoto
Donna L. Leonetti
Marguerite J. McNeely
Knut Borch-Johnsen
Edward J. Boyko
Dorte Vistisen
Beverley Balkau
on behalf of the DETECT-2 Study Group
DESIR Study Group
Publication date
01-01-2014
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 1/2014
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-013-3058-y

Other articles of this Issue 1/2014

Diabetologia 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.